- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 680
Daily deal net August 8, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Aug 8, 2019SoftBank sees to C2FO in $200m round
Business lending marketplace C2FO has collected $200m in a round led by SoftBank Vision Fund that reportedly included Allianz X.
Aug 8, 2019Cockroach Labs locks in $55m series C
The open-source database developer has now raised more than $108m in total, having secured $55m in a round backed by Alphabet's GV unit.
Aug 8, 2019LanzaTech lands $72m from Novo
Novo provided $72m in series E funding for the waste-to-ethanol technology producer, which counts the likes of Mitsui, Siemens and Petronas as existing investors.
Aug 8, 2019HawkEye 360 beams in $70m
Allied Minds has returned again for a series B round that took the firm's geospatial data analytics technology subsidiary's total funding to about $96m.
Aug 8, 2019HawkEye 360 beams in $70m
Airbus and Ebri were among the participants in a series B round that took the geospatial data analytics technology developer's total funding to about $96m.
Aug 8, 2019Hillrom inhales Breathe Technologies in $130m deal
Hillrom is paying $130m to snap up Johnson & Johnson-backed respiratory therapy system developer Breathe, which had raised at least $62m in funding.
Aug 8, 2019BlockFi rocks series A round
SIG, CM Group, Consensys Ventures and Akuna Capital all contributed to an $18.3m round for the cryptocurrency-based lending platform.
Aug 8, 2019SurveyMonkey swings to $68m GetFeedback purchase
SurveyMonkey has acquired the Campaign Monitor-owned online enterprise survey provider in a $68m deal that will give equity to Salesforce Ventures.
Aug 8, 2019Cleave Therapeutics clasps $12m
Celgene and Astellas Venture Management each supplied a portion of the round to bring the Caltech-founded cancer drug developer's lifetime funding to $92m.
Aug 8, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


